Application Sponsors
ANDA 216557 | AUROBINDO PHARMA | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 30MG | 0 | ISOSORBIDE MONONITRATE | ISOSORBIDE MONONITRATE |
002 | TABLET, EXTENDED RELEASE;ORAL | 60MG | 0 | ISOSORBIDE MONONITRATE | ISOSORBIDE MONONITRATE |
003 | TABLET, EXTENDED RELEASE;ORAL | 120MG | 0 | ISOSORBIDE MONONITRATE | ISOSORBIDE MONONITRATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-11-07 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
AUROBINDO PHARMA
cder:Array
(
[0] => Array
(
[ApplNo] => 216557
[companyName] => AUROBINDO PHARMA
[docInserts] => ["",""]
[products] => [{"drugName":"ISOSORBIDE MONONITRATE","activeIngredients":"ISOSORBIDE MONONITRATE","strength":"30MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ISOSORBIDE MONONITRATE","activeIngredients":"ISOSORBIDE MONONITRATE","strength":"60MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ISOSORBIDE MONONITRATE","activeIngredients":"ISOSORBIDE MONONITRATE","strength":"120MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/07\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-11-07
)
)